GBE Deficiency (GSD IV and APBD) Natural History Study

Last updated: May 27, 2025
Sponsor: Duke University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Liver Disorders

Treatment

No intervention

Clinical Study ID

NCT02683512
Pro00060753
  • Ages < 90
  • All Genders

Study Summary

Collection and review of clinical information related to glycogen branching enzyme (GBE) deficiency, diagnosed as Glycogen Storage Disease Type IV (GSD IV) or Adult Polyglucosan Body Disease (APBD generated during clinic visits.

Eligibility Criteria

Inclusion

  • Diagnosis of GSD IV or APBD via:

  • Two variants in the GBE1 gene

  • Deficient GBE activity in liver, muscle, skin fibroblast or other tissue

  • One variant in GBE1 gene with evidence of disease that is pathogenic, per the clinician

  • Able to provide informed consent for self (adults) or affected individual (minor or adults with a legally authorized representative)

  • Able to provide consent for release of medical records

  • Pregnant women with a diagnosis of GSD IV or APBD will be included

  • Histology as confirmed by clinician

Study Design

Total Participants: 200
Treatment Group(s): 1
Primary Treatment: No intervention
Phase:
Study Start date:
December 01, 2015
Estimated Completion Date:
December 31, 2035

Study Description

This natural history study will serve as a repository of clinical, laboratory, and biochemical information on individuals with GBE deficiency, diagnosed as either GSD IV or APBD. This information will allow a more definitive description of GBE deficiency to be developed, which will permit development of treatment strategies for this disease.

Duke will be the only site where this study takes place. However, since this is a rare disorder, participants who receive care for GBE deficiency at other institutions will be included. We will collect retrospective data from patient charts on diagnosed individuals, as far back as necessary to capture the clinical course of the disorder. Prospective data collected from patient charts after enrollment will be captured as well. Participant's medical records will be continually reviewed for the duration of the study.

Data will be collected from medical records and will only pertain to clinically relevant information, including, but not limited to: demographic and diagnostic information, tissue biopsy results, medical and family history, review of systems, imaging studies, results of liver, muscle, and nerve function testing, and urine and blood laboratory results.

Connect with a study center

  • Duke University Medical Center

    Durham, North Carolina 27710
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.